Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 2
1947 7
1948 5
1949 4
1950 7
1951 5
1952 8
1953 4
1954 7
1955 3
1956 4
1957 6
1958 6
1959 4
1960 2
1961 1
1963 3
1964 2
1965 15
1966 15
1967 15
1968 19
1969 12
1970 24
1971 29
1972 17
1973 24
1974 28
1975 30
1976 19
1977 32
1978 25
1979 31
1980 28
1981 38
1982 33
1983 27
1984 49
1985 66
1986 46
1987 63
1988 29
1989 45
1990 61
1991 51
1992 55
1993 56
1994 73
1995 62
1996 64
1997 59
1998 67
1999 88
2000 77
2001 98
2002 103
2003 118
2004 122
2005 104
2006 121
2007 127
2008 122
2009 119
2010 152
2011 159
2012 173
2013 209
2014 195
2015 210
2016 178
2017 229
2018 266
2019 285
2020 364
2021 360
2022 335
2023 336
2024 109

Text availability

Article attribute

Article type

Publication date

Search Results

5,373 results

Results by year

Filters applied: . Clear all
Page 1
Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.
Zhou C, Li X, Wang C, Zhang J. Zhou C, et al. Clin Rev Allergy Immunol. 2021 Dec;61(3):403-423. doi: 10.1007/s12016-021-08883-0. Epub 2021 Aug 17. Clin Rev Allergy Immunol. 2021. PMID: 34403083 Review.
Alopecia areata (AA) is a common chronic tissue-specific autoimmune disease, resulting in hair loss, that affects up to 2% of the general population. The exact pathobiology of AA has still remained elusive, while the common theory is the collapse of the immune privilege of …
Alopecia areata (AA) is a common chronic tissue-specific autoimmune disease, resulting in hair loss, that affects up to 2% of the gen …
Platelet-Rich Plasma for Hair Restoration.
Justicz N, Derakhshan A, Chen JX, Lee LN. Justicz N, et al. Facial Plast Surg Clin North Am. 2020 May;28(2):181-187. doi: 10.1016/j.fsc.2020.01.009. Epub 2020 Mar 2. Facial Plast Surg Clin North Am. 2020. PMID: 32312505 Review.
Pediatric Alopecia Areata.
Afford R, Leung AKC, Lam JM. Afford R, et al. Curr Pediatr Rev. 2021;17(1):45-54. doi: 10.2174/1573396316666200430084825. Curr Pediatr Rev. 2021. PMID: 32351186 Review.
It is the third most common dermatologic presentation in children with a lifetime risk of 1-2%. Diagnosing AA can be made on the basis of the history and clinical findings. ...
It is the third most common dermatologic presentation in children with a lifetime risk of 1-2%. Diagnosing AA can be made on the basi …
Emerging drugs for the treatment of alopecia areata.
Ramírez-Marín HA, Tosti A. Ramírez-Marín HA, et al. Expert Opin Emerg Drugs. 2022 Dec;27(4):379-387. doi: 10.1080/14728214.2022.2149735. Epub 2022 Nov 21. Expert Opin Emerg Drugs. 2022. PMID: 36408593 Review.
INTRODUCTION: Alopecia Areata (AA) is the second most common non-scarring hair loss disorder, with a prevalence of 1 in 1000 and a lifetime incidence of 2% worldwide. Data from a recent American study shows that from 68,121 patients with the diagnosis of AA, 37,995 (55.8%) …
INTRODUCTION: Alopecia Areata (AA) is the second most common non-scarring hair loss disorder, with a prevalence of 1 in 1000 and a lifetime …
Melatonin and the Human Hair Follicle.
Babadjouni A, Reddy M, Zhang R, Raffi J, Phong C, Mesinkovska N. Babadjouni A, et al. J Drugs Dermatol. 2023 Mar 1;22(3):260-264. doi: 10.36849/JDD.6921. J Drugs Dermatol. 2023. PMID: 36877877 Review.
RESULTS: A total of 11 human studies were identified with evidence of melatonin use in subjects with diagnosed alopecia (2,267 patients; 1,140M). Eight of the studies reviewed observed positive outcomes after topical melatonin use in subjects with androgenetic alopecia (AG …
RESULTS: A total of 11 human studies were identified with evidence of melatonin use in subjects with diagnosed alopecia (2,267 patien …
Alopecia areata: Current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines.
Fukuyama M, Ito T, Ohyama M. Fukuyama M, et al. J Dermatol. 2022 Jan;49(1):19-36. doi: 10.1111/1346-8138.16207. Epub 2021 Oct 28. J Dermatol. 2022. PMID: 34709679 Review.
AA had been recognized as type 1 inflammatory disease, but recent investigations have suggested some roles of type 2- and Th17-associated mediators in AA pathogenesis. The significance of psychological stress in AA pathogenesis is less emphasized nowadays, but psychologica …
AA had been recognized as type 1 inflammatory disease, but recent investigations have suggested some roles of type 2- and Th17-associ …
Off-Label Use of Topical Minoxidil in Alopecia: A Review.
Stoehr JR, Choi JN, Colavincenzo M, Vanderweil S. Stoehr JR, et al. Am J Clin Dermatol. 2019 Apr;20(2):237-250. doi: 10.1007/s40257-018-0409-y. Am J Clin Dermatol. 2019. PMID: 30604379 Review.
Conditions for which the use of topical minoxidil has been reported include telogen effluvium, alopecia areata (AA), scarring alopecia, eyebrow hypotrichosis, monilethrix, and chemotherapy-induced alopecia (CIA). ...For certain conditions, including AA and most scarring al …
Conditions for which the use of topical minoxidil has been reported include telogen effluvium, alopecia areata (AA), scarring alopecia, eyeb …
Evaluation and diagnosis of the hair loss patient: part I. History and clinical examination.
Mubki T, Rudnicka L, Olszewska M, Shapiro J. Mubki T, et al. J Am Acad Dermatol. 2014 Sep;71(3):415.e1-415.e15. doi: 10.1016/j.jaad.2014.04.070. J Am Acad Dermatol. 2014. PMID: 25128118 Review.
Therefore, an organized and systematic approach is needed to accurately address patients' complaints to achieve the correct diagnosis. Part 1 of this 2-part continuing medical education article on alopecia describes history taking and the clinical examination of different …
Therefore, an organized and systematic approach is needed to accurately address patients' complaints to achieve the correct diagnosis. Part …
Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose.
Villani A, Fabbrocini G, Ocampo-Candiani J, Ruggiero A, Ocampo-Garza SS. Villani A, et al. J Eur Acad Dermatol Venereol. 2021 Jul;35(7):1485-1492. doi: 10.1111/jdv.17216. Epub 2021 Mar 23. J Eur Acad Dermatol Venereol. 2021. PMID: 33660357 Review.
Available literature suggests women require lower doses, from 0.25 to 2.5 mg daily, while men require higher doses for maximal efficacy, from 1.25 to 5 mg a day....
Available literature suggests women require lower doses, from 0.25 to 2.5 mg daily, while men require higher doses for maximal effica …
5,373 results